Estados Unidos - inglés - NLM (National Library of Medicine)

lannett company, inc. - fludarabine phosphate (unii: 1x9vk9o1sc) (fludarabine - unii:p2k93u8740) - fludarabine phosphate injection is indicated for the treatment of adult patients with b-cell chronic lymphocytic leukemia (cll) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen. the safety and effectiveness of fludarabine phosphate injection in previously untreated or non-refractory patients with cll have not been established. none [see warnings and precautions (5.6)]. based on its mechanism of action, fludarabine phosphate can cause fetal harm when administered to a pregnant woman. there are no adequate and well-controlled studies of fludarabine phosphate injection in pregnant women. in rats, repeated intravenous doses of fludarabine phosphate at 2.4 times and 7.2 times the recommended human intravenous dose (25 mg/m 2 ) administered during organogenesis caused an increase in resorptions, skeletal and visceral malformations (cleft palate, exencephaly, and fetal vertebrae deformities) and decreased fetal body weights. m

Canadá - inglés - Health Canada

mylan pharmaceuticals ulc - fludarabine phosphate - solution - 25mg - fludarabine phosphate 25mg - antineoplastic agents

Canadá - inglés - Health Canada

teva canada limited - fludarabine phosphate - solution - 25mg - fludarabine phosphate 25mg - antineoplastic agents

Canadá - inglés - Health Canada

fresenius kabi canada ltd - fludarabine phosphate - solution - 25mg - fludarabine phosphate 25mg - antineoplastic agents

Canadá - inglés - Health Canada

fresenius kabi canada ltd - fludarabine phosphate - powder for solution - 50mg - fludarabine phosphate 50mg - antineoplastic agents

Canadá - inglés - Health Canada

omega laboratories limited - fludarabine phosphate - liquid - 25mg - fludarabine phosphate 25mg - antineoplastic agents

Canadá - inglés - Health Canada

accord healthcare inc - fludarabine phosphate - solution - 25mg - fludarabine phosphate 25mg - antineoplastic agents

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - fludarabine phosphate - powder for solution for injection - 50mg

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - fludarabine phosphate - solution for injection - 25mg/1ml

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

pharmachemie bv - fludarabine phosphate - concentrate for soln for inj - 25 mg/ml - purine analogues